ShellyPKafkaMD(She/Her)

Rheumatology • East Norriton, PA

Medical Director, Cross Innovation and Pipeline Team Abbvie Pharmaceuticals

Join to view full profile

Dr. Kafka is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kafka's full profile

Already have an account?

Office
Caspian Lane
East Norriton, PA 19403
Phone+1 814-935-3724

Education & Training

University of RochesterFellowship, Rheumatology, 1990 - 1993
Vanderbilt University Medical CenterResidency, Internal Medicine, 1988 - 1990
Vanderbilt University School of MedicineClass of 1988

Certifications & Licensure

WV State Medical License 2005 - 2016
PA State Medical License 2000 - 2012

Awards, Honors, & Recognition

Fellow (FACR) American College of Rheumatology

Clinical Trials

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
Completed
Phase 3
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus Start of enrollment: 2014 Jan 01
Terminated
Phase 3
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Completed
Phase 3

Publications & Presentations

PubMed

3 citations
Machine Learning Applied to Patient-Reported Outcomes to Classify Physician-Derived Measures of Rheumatoid Arthritis Disease Activity.
Jeffrey R Curtis, Yujie Su, Shawn Black, Stephen Xu, Wayne Langholff
ACR Open Rheumatology. 2022-12-01
15 citations
Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies.
Dennis McGonagle, Iain B. McInnes, Atul Deodhar, Georg Schett, May Shawi
Rheumatology. 2021-11-03
6 citations
Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study.
Jeffrey R. Curtis, Soumya D. Chakravarty, Shawn Black, S. Kafka, Stephen Xu
Rheumatology and Therapy. 2021-08-20

Professional Memberships

American College of Rheumatology - ACR
Fellow